CN1950103B - 生长激素c端片段在制造药物中的应用 - Google Patents

生长激素c端片段在制造药物中的应用 Download PDF

Info

Publication number
CN1950103B
CN1950103B CN2005800144115A CN200580014411A CN1950103B CN 1950103 B CN1950103 B CN 1950103B CN 2005800144115 A CN2005800144115 A CN 2005800144115A CN 200580014411 A CN200580014411 A CN 200580014411A CN 1950103 B CN1950103 B CN 1950103B
Authority
CN
China
Prior art keywords
application
bone
growth hormone
peptide
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2005800144115A
Other languages
English (en)
Chinese (zh)
Other versions
CN1950103A (zh
Inventor
E·沃斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolic Pharmaceuticals Pty Ltd
Original Assignee
Metabolic Pharmaceuticals Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004902388A external-priority patent/AU2004902388A0/en
Application filed by Metabolic Pharmaceuticals Pty Ltd filed Critical Metabolic Pharmaceuticals Pty Ltd
Publication of CN1950103A publication Critical patent/CN1950103A/zh
Application granted granted Critical
Publication of CN1950103B publication Critical patent/CN1950103B/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CN2005800144115A 2004-05-04 2005-05-04 生长激素c端片段在制造药物中的应用 Expired - Fee Related CN1950103B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2004902388 2004-05-04
AU2004902388A AU2004902388A0 (en) 2004-05-04 Methods for preventing or treating bone disorders
PCT/AU2005/000638 WO2005105132A1 (en) 2004-05-04 2005-05-04 Methods for preventing or treating bone disorders

Publications (2)

Publication Number Publication Date
CN1950103A CN1950103A (zh) 2007-04-18
CN1950103B true CN1950103B (zh) 2011-04-13

Family

ID=35241438

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2005800144115A Expired - Fee Related CN1950103B (zh) 2004-05-04 2005-05-04 生长激素c端片段在制造药物中的应用

Country Status (8)

Country Link
US (1) US8008433B2 (enExample)
EP (1) EP1755637B8 (enExample)
JP (1) JP4931802B2 (enExample)
CN (1) CN1950103B (enExample)
AU (1) AU2005237187B2 (enExample)
CA (1) CA2564169C (enExample)
ES (1) ES2391853T3 (enExample)
WO (1) WO2005105132A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103987402A (zh) * 2011-12-09 2014-08-13 麦特保利药业有限公司 生长激素片段的用途

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110092448A1 (en) * 2005-08-02 2011-04-21 Metabolic Pharmaceuticals Limited Peptide Conjugate for Oral Delivery of Hydrophilic Peptide Analgesics
WO2007068039A1 (en) * 2005-12-12 2007-06-21 Metabolic Pharmaceuticals Limited Treatment of weight gain in estrogen deficient mammals
IT202100002228A1 (it) * 2021-02-02 2022-08-02 Univ Degli Studi Milano Composizione per ridurre gli squilibri metabolici conseguenti all'insufficienza ovarica

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1127000A (zh) * 1993-07-13 1996-07-17 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽：合成和治疗骨质疏松症的用途
CN1275132A (zh) * 1997-09-08 2000-11-29 新陈代谢药物有限公司 肥胖症的治疗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1200432B1 (en) * 1999-07-13 2004-05-12 Merck & Co., Inc. Amido spiropiperidines promote the release of growth hormone
AUPQ387599A0 (en) 1999-11-05 1999-12-02 Metabolic Pharmaceuticals Limited Product and method for control of obesity
AU2001285145A1 (en) * 2000-08-21 2002-03-04 Millennium Pharmaceuticals, Inc. Human abc transporter family member and uses thereof
EP1556084A4 (en) 2002-10-07 2006-01-11 Zymogenetics Inc METHOD FOR REGULATING THE BODY WEIGHT

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1127000A (zh) * 1993-07-13 1996-07-17 森德克斯(美国)股份有限公司 甲状旁腺激素类似物和甲状旁腺激素相关肽：合成和治疗骨质疏松症的用途
CN1275132A (zh) * 1997-09-08 2000-11-29 新陈代谢药物有限公司 肥胖症的治疗

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Paoletti AM et al..Efficacy and safety of oral and transdermalhormonalreplacement treatment containing levonorgestrel.Maturitas42 2.2002,42(2),137-147.
Paoletti AM et al..Efficacy and safety of oral and transdermalhormonalreplacement treatment containing levonorgestrel.Maturitas42 2.2002,42(2),137-147. *
赵安.甲状旁腺激素相关肽与骨质疏松.国外医学药学分册28 2.2001,28(2),84-87.
赵安.甲状旁腺激素相关肽与骨质疏松.国外医学药学分册28 2.2001,28(2),84-87. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103987402A (zh) * 2011-12-09 2014-08-13 麦特保利药业有限公司 生长激素片段的用途
CN103987402B (zh) * 2011-12-09 2019-06-18 麦特保利药业有限公司 生长激素片段的用途

Also Published As

Publication number Publication date
JP2007536282A (ja) 2007-12-13
US20080131521A1 (en) 2008-06-05
CA2564169A1 (en) 2005-11-10
EP1755637B1 (en) 2012-08-29
AU2005237187A1 (en) 2005-11-10
AU2005237187B2 (en) 2010-10-28
EP1755637A1 (en) 2007-02-28
US8008433B2 (en) 2011-08-30
JP4931802B2 (ja) 2012-05-16
CN1950103A (zh) 2007-04-18
EP1755637A4 (en) 2009-08-19
ES2391853T3 (es) 2012-11-30
CA2564169C (en) 2014-04-01
WO2005105132A1 (en) 2005-11-10
EP1755637B8 (en) 2012-10-03

Similar Documents

Publication Publication Date Title
JP3053116B2 (ja) 医薬組成物
JP2557779B2 (ja) ２成分型骨粗鬆症用薬剤
US20070099831A1 (en) Parathyroid hormone analogues and methods of use
CZ298701B6 (cs) Lécivo pro hojení kostí a reparaci zlomenin
US9610320B2 (en) Surgical applications for BMP binding protein
US20130095075A1 (en) Bone morphogenic protein binding peptide
KR20110100269A (ko) 감소된 프로테아제 활성을 갖는 골 이식편 및 선택 방법 및 용도
US20130095139A1 (en) Bone morphogenic protein binding peptide
US20160000860A1 (en) Enhancement of bmp retention
US20080176787A1 (en) Parathyroid hormone analogues and methods of use
YAMAMOTO et al. Calcitonin-induced anorexia in rats: a structure-activity study by intraventricular injections
US8008433B2 (en) Methods for preventing or treating bone disorders
Barlet et al. Synthetic parathyroid hormone-related peptide (1–34) fragment stimulates placental calcium transfer in ewes
US20070270341A1 (en) Parathyroid hormone analogues and methods of use
US20050197286A1 (en) Method for control of depression using c terminal growth hormone (gh) fragment
CN1355813A (zh) 具有preptin功能的肽
US20090010940A1 (en) Parathyroid Hormone Analogues and Methods of Use
JP2010501476A (ja) 副甲状腺ホルモン類似体およびその使用方法
CN114057863B (zh) 一种甲状旁腺激素相关肽类似物及其应用
WO2007068039A1 (en) Treatment of weight gain in estrogen deficient mammals
US20090042774A1 (en) Parathyroid hormone analogues and methods of use

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110413

Termination date: 20210504